{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:22:43Z","timestamp":1778883763731,"version":"3.51.4"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T00:00:00Z","timestamp":1427673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0117429","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T12:54:34Z","timestamp":1427806474000},"page":"e0117429","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pre-Existing Mutations in Reverse Transcriptase of Hepatitis B Virus in Treatment-Naive Chinese Patients with Chronic Hepatitis B"],"prefix":"10.1371","volume":"10","author":[{"given":"Jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2014natural history and clinical consequences","volume":"350","author":"D Ganem","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"3","article-title":"Management of hepatitis B in China","volume":"122","author":"FM Lu","year":"2009","journal-title":"Chin Med J (Engl)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"M Nassal","year":"2008","journal-title":"Virus Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1073\/pnas.93.9.4398","article-title":"Viral dynamics in hepatitis B virus infection","volume":"93","author":"MA Nowak","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jac\/dkn014","article-title":"Hepatitis B virus escape mutants induced by antiviral therapy","volume":"61","author":"J Sheldon","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/jhep.2001.22166","article-title":"Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region","volume":"33","author":"LJ Stuyver","year":"2001","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2893.2005.00713.x","article-title":"Mutations affecting the replication capacity of the hepatitis B virus","volume":"13","author":"J Sheldon","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1386-6532(02)00049-5","article-title":"The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus","volume":"25","author":"J Torresi","year":"2002","journal-title":"J Clin Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1743-422X-10-292","article-title":"Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants","volume":"10","author":"M Zhang","year":"2013","journal-title":"Virol J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/jmv.20974","article-title":"Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients","volume":"79","author":"SG Selabe","year":"2007","journal-title":"J Med Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep.26383","article-title":"Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing","volume":"58","author":"C Rodriguez","year":"2013","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.22841","article-title":"Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-na\u00efve patients is rare through 5 years of therapy","volume":"49","author":"DJ Tenney","year":"2009","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/MEG.0b013e32835ee516","article-title":"Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine","volume":"25","author":"Y Zhang","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1440-1746.2002.02767.x","article-title":"Treatment of chronic hepatitis B: case selection and duration of therapy","volume":"17","author":"N Leung","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase","volume":"125","author":"P Angus","year":"2003","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2012.02.003","article-title":"The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation","volume":"54","author":"D1 Ji","year":"2012","journal-title":"J Clin Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3851\/IMP1702","article-title":"Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B","volume":"16","author":"KH Han","year":"2011","journal-title":"Antivir Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/j.1365-2893.2010.01360.x","article-title":"Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection","volume":"18","author":"Y Liu","year":"2011","journal-title":"J Viral Hepat"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.antiviral.2009.12.006","article-title":"Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-na\u00efve Chinese patients","volume":"85","author":"BM Liu","year":"2010","journal-title":"Antiviral Res"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.diagmicrobio.2014.01.005","article-title":"Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method","volume":"79","author":"S Ciftci","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref21","first-page":"835","article-title":"Frequency and mutation patterns of resistance in patients with chronic hepatitis B infection treated with nucleos(t)ide analogs in add-on and switch strategies","volume":"11","author":"M Sayan","year":"2011","journal-title":"Hepat Mon"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"F Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/135965350901400504","article-title":"Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients","volume":"14","author":"T Pollicino","year":"2009","journal-title":"Antivir Ther"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jmv.23608","article-title":"Hepatitis B virus reverse transcriptase mutations in treatment Na\u00efve chronic hepatitis B patients","volume":"85","author":"B Singla","year":"2013","journal-title":"J Med Virol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3748\/wjg.v11.i6.867","article-title":"YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines","volume":"11","author":"ZM Huang","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clinthera.2009.02.016","article-title":"Evolution of hepatitis B virus polymerase mutations in a patient with HBeAg-positive chronic hepatitis B virus treated with sequential monotherapy and add-on nucleoside\/nucleotide analogues","volume":"31","author":"F Wang","year":"2009","journal-title":"Clin Ther"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1128\/JCM.43.5.2503-2505.2005","article-title":"Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy","volume":"43","author":"B Z\u00f6llner","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2012.02.003","article-title":"The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation","volume":"54","author":"D Ji","year":"2012","journal-title":"J Clin Virol"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Liu Y, Li X, Xin S, Xu Z, Chen R, et al. (2014) The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil. J Viral Hepat doi: 10.1111 [Epub ahead of print]","DOI":"10.1111\/jvh.12298"},{"issue":"4","key":"ref30","first-page":"484","article-title":"Resistance to adefovir in patients with chronic hepatitis B","volume":"12","author":"SH Ryu","year":"2006","journal-title":"Korean J Hepatol"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2002.34740","article-title":"Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks","volume":"36","author":"H Yang","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jinf.2013.05.008","article-title":"Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen","volume":"67","author":"V Cento","year":"2013","journal-title":"J Infect"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1386-6532(02)00049-5","article-title":"The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus","volume":"25","author":"J Torresi","year":"2002","journal-title":"J Clin Virol"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Liu Y, Li X, Xin S, Xu Z, Chen R, et al. (2014) The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil. J Viral Hepat <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1111\/jvh.12298\" xlink:type=\"simple\">10.1111\/jvh.12298<\/ext-link><\/comment> [Epub ahead of print]","DOI":"10.1111\/jvh.12298"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1099\/vir.0.066886-0","article-title":"Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility","volume":"95","author":"J Fan","year":"2014","journal-title":"J Gen Virol"},{"issue":"Suppl","key":"ref36","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1136\/gutjnl-2012-302056","article-title":"New insight in the pathobiology of hepatitis B virus infection","volume":"61","author":"M Dandri","year":"2012","journal-title":"Gut"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.83.6.1578","article-title":"Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen","volume":"83","author":"JH Ou","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JVI.65.9.5080-5083.1991","article-title":"Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment","volume":"65","author":"J Wang","year":"1991","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e39591","DOI":"10.1371\/journal.pone.0039591","article-title":"Mathematical models of e-antigen mediated immune tolerance and activation following prenatal HBV infection","volume":"7","author":"SM Ciupe","year":"2012","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/JVI.71.3.2192-2201.1997","article-title":"The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype","volume":"71","author":"DR Milich","year":"1997","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.4049\/jimmunol.160.4.2013","article-title":"The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence","volume":"160","author":"DR Milich","year":"1998","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jmv.20835","article-title":"A putative new domain target for anti-hepatitis B virus: residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306)","volume":"79","author":"YX Wang","year":"2007","journal-title":"J Med Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep.510270243","article-title":"Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective","volume":"27","author":"M Melegari","year":"1998","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.22790","article-title":"The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains","volume":"49","author":"S Amini-Bavil-Olyaee","year":"2009","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3851\/IMP1791","article-title":"The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations","volume":"22","author":"Y Zhu","year":"2011","journal-title":"Antivir Chem Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0117429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T02:56:22Z","timestamp":1691549782000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0117429"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Paraskevis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,30]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0117429","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,30]]}}}